UCB’s Neupro Manufacturing Problems Hold Up Approval For Advanced Parkinson’s Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
UCB must resolve the issue of drug crystal formation in the Neupro patch before it can be approved for two supplemental indications.